"10.1371_journal.pone.0019499","plos one","2011-04-29T00:00:00Z","Michael A Curran; Myoungjoo Kim; Welby Montalvo; Aymen Al-Shamkhani; James P Allison","Howard Hughes Medical Institute, Department of Immunology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Cancer Sciences Division, University of Southampton School of Medicine, Southampton General Hospital, Southampton, United Kingdom","Conceived and designed the experiments: MAC JPA. Performed the experiments: MAC MK WM. Analyzed the data: MAC MK JPA. Contributed reagents/materials/analysis tools: AA-S. Wrote the paper: MAC. Proof-read manuscript: JPA MK AA-S.","Dr. James P. Allison is a paid consultant for Bristol-Myers Squib and is the primary inventor on the patent Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling (US Patent 7229628; Submitted 12/07/199; Published: 06/12/2007) which has been been licensed by UC Berkeley to Bristol-Myers Squib. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","04","Michael A Curran","MAC",5,TRUE,2,3,3,1,TRUE,TRUE,FALSE,0,NA,FALSE
